1-2 of 2
Keywords: PEG interferon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin: A Prospective Randomized Controlled Trial

Available to Purchase
Subject Area:
Further Areas
Shintaro Takaki, Yoshiiku Kawakami, Michio Imamura, Hiroshi Aikata, Shoichi Takahashi, Hiroto Ishihara, Keiji Tsuji, Shiomi Aimitsu, Hiroiku Kawakami, Toshio Nakanishi, Mikiya Kitamoto, Takashi Moriya, Kenichi Satoh, Kazuaki Chayama
Journal: Intervirology
Intervirology (2008) 50 (6): 439–446.
https://doi.org/10.1159/000114718
Published Online: 04 February 2008
..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chronic hepatitis C Ribavirin PEG interferon Combination therapy Anemia...
View articletitled, Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin: A Prospective Randomized Controlled Trial
Open the PDF for Eicosapentaenoic Acid Could Permit Maintenance of the Original Ribavirin Dose in Chronic Hepatitis C Virus Patients during the First 12 Weeks of Combination Therapy with Pegylated Interferon-α and Ribavirin: A Prospective Randomized Controlled Trial in another window
Journal Articles

A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load

Available to Purchase
Subject Area:
Further Areas
Namiki Izumi, Yasuhiro Asahina, Masayuki Kurosaki, Masakatsu Uchihara, Yuki Nishimura, Kazunari Inoue, Ken Ueda, Kaoru Tsuchiya, Kousei Hamano, Jun Itakura, Shozo Miyake
Journal: Intervirology
Intervirology (2004) 47 (2): 102–107.
https://doi.org/10.1159/000077833
Published Online: 11 June 2004
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chronic hepatitis C HCV dynamics PEG interferon Ribavirin Genotype 1 Original Paper Intervirology 2004;47:102 107 DOI: 10.1159/000077833...
View articletitled, A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load
Open the PDF for A Comparison of the Exponential Decay Slope between PEG-IFN alfa-2b/Ribavirin and IFN alfa-2b/Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Genotype 1b Infection and a High Viral Load in another window